GenapSys is partnering with Chinese health authorities to use its portable sequencer for detecting 2019-nCoV novel coronavirus, as part of the company’s launch of its instrument in the Asia-Pacific region . . .
GenapSys Pursues Partnership with China CDC to Detect Coronavirus
Company Launches Portable Sequencers in Asia-Pacific Region, Raises $75M in Latest Financing
GenapSys CEO and Founder Hesaam Esfandyarpour, PhD, says his company’s portable sequencer is about the size of an iPad, costs under $10,000, and is based on a proprietary direct electronic sequencing chip, which is intended to eliminate the need for cumbersome equipment. [Alex Philippidis]
